Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

15.40
Delayed Data
As of Jan 13
 +0.49 / +3.29%
Today’s Change
9.02
Today|||52-Week Range
16.37
+16.40%
Year-to-Date
No recent news for Insmed Inc.

Today’s Trading

Previous close14.91
Today’s open14.95
Day’s range14.94 - 15.67
Volume325,303
Average volume (3 months)298,631
Market cap$952.9M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-9.78%
Earnings growth (this year)-31.06%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.10+0.78%
LOXOLoxo Oncology Inc-1.34-3.39%
ACORAcorda Therapeutics ...+0.60+2.88%
CORTCorcept Therapeutics...+0.01+0.12%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$0.00
Annual profit (last year)-$118.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Will Lewis
Chief Financial Officer
Andrew T. Drechsler
Corporate headquarters
Bridgewater, New Jersey

Forecasts


Search for Jobs